BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37880897)

  • 1. Fully Active Delivery of Nanodrugs In Vivo via Remote Optical Manipulation.
    Liu X; Wu S; Wu H; Zhang T; Qin H; Lin Y; Li B; Jiang X; Zheng X
    Small Methods; 2024 Jan; 8(1):e2301112. PubMed ID: 37880897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanodrugs to target articular cartilage: An emerging platform for osteoarthritis therapy.
    Bottini M; Bhattacharya K; Fadeel B; Magrini A; Bottini N; Rosato N
    Nanomedicine; 2016 Feb; 12(2):255-68. PubMed ID: 26707894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optically Programmable Living Microrouter in Vivo.
    Liu X; Wu H; Wu S; Qin H; Zhang T; Lin Y; Zheng X; Li B
    Adv Sci (Weinh); 2023 Nov; 10(32):e2304103. PubMed ID: 37749869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine: de novo design of nanodrugs.
    Yang Z; Kang SG; Zhou R
    Nanoscale; 2014 Jan; 6(2):663-77. PubMed ID: 24305636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine therapeutic approaches to overcome cancer drug resistance.
    Markman JL; Rekechenetskiy A; Holler E; Ljubimova JY
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1866-79. PubMed ID: 24120656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier-free nanodrugs for safe and effective cancer treatment.
    Karaosmanoglu S; Zhou M; Shi B; Zhang X; Williams GR; Chen X
    J Control Release; 2021 Jan; 329():805-832. PubMed ID: 33045313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanodrugs as a New Approach in the Therapy of Cardiovascular Diseases and Cancer with Tumor-associated Angiogenesis.
    Hajtuch J; Niska K; Inkielewicz-Stepniak I
    Curr Med Chem; 2021; 28(27):5527-5550. PubMed ID: 33390102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Experimental Approach to Understand the Transport of Nanodrugs.
    Palchoudhury S; Das P; Ghasemi A; Tareq SM; Sengupta S; Han J; Maglosky S; Almanea F; Jones M; Cox C; Rao V
    Materials (Basel); 2023 Aug; 16(15):. PubMed ID: 37570188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research progress of novel inorganic nanometre materials carriers in nanomedicine for cancer diagnosis and treatment.
    Xu J; Liao K; Jiang H; Zhou W
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S492-S502. PubMed ID: 30449177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Propelled Gemini-like LMWH-Scaffold Nanodrugs for Overall Tumor Microenvironment Manipulation via Macrophage Reprogramming and Vessel Normalization.
    Xu C; Yang S; Jiang Z; Zhou J; Yao J
    Nano Lett; 2020 Jan; 20(1):372-383. PubMed ID: 31840517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revitalizing Ancient Mitochondria with Nano-Strategies: Mitochondria-Remedying Nanodrugs Concentrate on Disease Control.
    Long X; Liu M; Nan Y; Chen Q; Xiao Z; Xiang Y; Ying X; Sun J; Huang Q; Ai K
    Adv Mater; 2024 May; 36(18):e2308239. PubMed ID: 38224339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles in Combating Cancer: Opportunities and Limitations. A Brief Review.
    Pedziwiatr-Werbicka E; Horodecka K; Shcharbin D; Bryszewska M
    Curr Med Chem; 2021; 28(2):346-359. PubMed ID: 32000637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening.
    Millard M; Yakavets I; Zorin V; Kulmukhamedova A; Marchal S; Bezdetnaya L
    Int J Nanomedicine; 2017; 12():7993-8007. PubMed ID: 29184400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart Peptide-Based Supramolecular Photodynamic Metallo-Nanodrugs Designed by Multicomponent Coordination Self-Assembly.
    Li S; Zou Q; Li Y; Yuan C; Xing R; Yan X
    J Am Chem Soc; 2018 Aug; 140(34):10794-10802. PubMed ID: 30102029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical evaluation of biodegradable polymers used in nanodrugs.
    Marin E; Briceño MI; Caballero-George C
    Int J Nanomedicine; 2013; 8():3071-90. PubMed ID: 23990720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor in 3D: In Vitro Complex Cellular Models to Improve Nanodrugs Cancer Therapy.
    Fernandes S; Cassani M; Pagliari S; Filipensky P; Cavalieri F; Forte G
    Curr Med Chem; 2020; 27(42):7234-7255. PubMed ID: 32586245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy.
    Huang L; Zhao S; Fang F; Xu T; Lan M; Zhang J
    Biomaterials; 2021 Jan; 268():120557. PubMed ID: 33260095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.